Search Results

There are 4672 results for: content related to: Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease

  1. Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 8, October 2015, Pages: 990–999, V. Chhaya, R. C. G. Pollok, E. Cecil, V. Subramanian, V. Curcin, A. Majeed and S. Saxena

    Version of Record online : 13 AUG 2015, DOI: 10.1111/apt.13361

  2. You have free access to this content
    The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders

    International Journal of Rheumatic Diseases

    Volume 17, Issue 2, February 2014, Pages: 132–141, Antony B. Friedman, Miles P. Sparrow and Peter R. Gibson

    Version of Record online : 6 NOV 2013, DOI: 10.1111/1756-185X.12204

  3. You have free access to this content
    The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: a national population-based study of incident cases between 1989–2009

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 1, January 2015, Pages: 87–98, V. Chhaya, S. Saxena, E. Cecil, S. Chatu, V. Subramanian, V. Curcin, A. Majeed and R. C. Pollok

    Version of Record online : 10 NOV 2014, DOI: 10.1111/apt.13017

  4. You have free access to this content
    Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 1, January 2012, Pages: 15–36, L. Chouchana, C. Narjoz, P. Beaune, M.-A. Loriot and X. Roblin

    Version of Record online : 2 NOV 2011, DOI: 10.1111/j.1365-2036.2011.04905.x

  5. Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

    Inflammatory Bowel Diseases

    Volume 16, Issue 9, September 2010, Pages: 1541–1549, B. Jharap, M.L. Seinen, N.K.H. de Boer, J.R. van Ginkel, R.K. Linskens, J.C. Kneppelhout, C.J.J. Mulder and A.A. van Bodegraven

    Version of Record online : 12 FEB 2010, DOI: 10.1002/ibd.21221

  6. Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 838–843, Lori A. Ashworth, Amy Billett, Paul Mitchell, Federica Nuti, Corey Siegel and Athos Bousvaros

    Version of Record online : 1 SEP 2011, DOI: 10.1002/ibd.21844

  7. You have free access to this content
    Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients – a POCER study analysis

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 7, October 2015, Pages: 867–879, P. De Cruz, M. A. Kamm, A. L. Hamilton, K. J. Ritchie, E. O. Krejany, A. Gorelik, D. Liew, L. Prideaux, I. C. Lawrance, J. M. Andrews, P. A. Bampton, S. Jakobovits, T. H. Florin, P. R. Gibson, H. Debinski, R. B. Gearry, F. A. Macrae, R. W. Leong, I. Kronborg, G. Radford-Smith, W. Selby, M. J. Johnston, R. Woods, P. R. Elliott, S. J. Bell, S. J. Brown, W. R. Connell and P. V. Desmond

    Version of Record online : 28 AUG 2015, DOI: 10.1111/apt.13353

  8. A practical guide to the use of thiopurines in oral medicine

    Journal of Oral Pathology & Medicine

    Volume 44, Issue 10, November 2015, Pages: 761–768, E. A. Hullah, P. A. Blaker, A. M. Marinaki, M. P. Escudier and J. D. Sanderson

    Version of Record online : 19 DEC 2014, DOI: 10.1111/jop.12274

  9. Clinical outcomes and prognostic factors for thiopurine maintenance therapy in patients with intestinal Behcet's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 4, April 2012, Pages: 750–757, Yoon Suk Jung, Jae Hee Cheon, Sung Pil Hong, Tae Il Kim and Won Ho Kim

    Version of Record online : 25 MAY 2011, DOI: 10.1002/ibd.21757

  10. You have free access to this content
    Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 2, July 2010, Pages: 119–130, M. A. Smith, P. M. Irving, A. M. Marinaki and J. D. Sanderson

    Version of Record online : 16 APR 2010, DOI: 10.1111/j.1365-2036.2010.04330.x

  11. You have free access to this content
    Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 8, April 2016, Pages: 863–883, W. Moon and E. V. Loftus Jr

    Version of Record online : 14 FEB 2016, DOI: 10.1111/apt.13559

  12. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 385–389, Mashiko Setshedi, David Epstein, Trevor A Winter, Landon Myer, Gillian Watermeyer and Richard Hift

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06865.x

  13. Safety and effectiveness of long-term allopurinol–thiopurine maintenance treatment in inflammatory bowel disease

    Inflammatory Bowel Diseases

    Frank Hoentjen, Margien L. Seinen, Stephen B. Hanauer, Nanne K.H. de Boer, David T. Rubin, Gerd Bouma, Laura E. Harrell and Adriaan A. van Bodegraven

    Version of Record online : 17 MAY 2012, DOI: 10.1002/ibd.23021

  14. You have full text access to this OnlineOpen article
    Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics

    British Journal of Haematology

    Volume 169, Issue 2, April 2015, Pages: 228–240, Lynne Lennard, Cher S. Cartwright, Rachel Wade and Ajay Vora

    Version of Record online : 29 NOV 2014, DOI: 10.1111/bjh.13240

  15. You have full text access to this OnlineOpen article
    Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1313–1323, N. A. Kennedy, R. Kalla, B. Warner, C. J. Gambles, R. Musy, S. Reynolds, R. Dattani, H. Nayee, R. Felwick, R. Harris, S. Marriott, S. M. Senanayake, C. A. Lamb, H. Al-Hilou, D. R. Gaya, P. M. Irving, J. Mansfield, M. Parkes, T. Ahmad, J. R. F. Cummings, I. D. Arnott, J. Satsangi, A. J. Lobo, M. Smith, J. O. Lindsay and C. W. Lees

    Version of Record online : 6 OCT 2014, DOI: 10.1111/apt.12980

  16. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 735–744, Florian Beigel, Anni Steinborn, Fabian Schnitzler, Cornelia Tillack, Simone Breiteneicher, Jestinah Mahachie John, Kristel Van Steen, Rüdiger P. Laubender, Burkhard Göke, Julia Seiderer, Stephan Brand and Thomas Ochsenkühn

    Version of Record online : 30 APR 2014, DOI: 10.1002/pds.3621

  17. You have free access to this content
    Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 2, January 2016, Pages: 252–261, A. Bourrier, F. Carrat, J.-F. Colombel, A.-M. Bouvier, V. Abitbol, P. Marteau, J. Cosnes, T. Simon, L. Peyrin-Biroulet, L. Beaugerie and the CESAME study group

    Version of Record online : 9 NOV 2015, DOI: 10.1111/apt.13466

  18. You have free access to this content
    IBD Clinical

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 82–111,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_6

  19. You have free access to this content
    The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic

    International Journal of Clinical Practice

    Volume 67, Issue 2, February 2013, Pages: 161–169, M. Smith, P. Blaker, C. Patel, A. Marinaki, M. Arenas, E. Escuredo, S. Anderson, P. Irving and J. Sanderson

    Version of Record online : 17 DEC 2012, DOI: 10.1111/ijcp.12039

  20. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 10, October 2013, Pages: 1595–1599, David E H Ong, Michael A Kamm, Juanda Leo Hartono and Mark Lust

    Version of Record online : 23 SEP 2013, DOI: 10.1111/jgh.12263